Alzheimer's advocate Tony Gonzales testified before the House Ways and Means Health Subcommittee, advocating for CMS coverage for FDA-approved Alzheimer's treatments. Bipartisan members of the subcommittee expressed their support for Gonzales and their desire for CMS to change its policy. There is mounting bipartisan political support for CMS to change its policy.